Hannover Rück SE

TickerHNR1.XETRA
Current Price
Hannover Rück SE – stock chart

5-year stock timeline

Hannover Rück's share history from 2020 through 2026 tells a story of shock, recovery, and quiet re-rating. The Covid-19 pandemic delivered a sharp blow in 2020 with substantial claims and underwriting losses, yet the company maintained dividend discipline with a €4.50 ordinary payout. Strategic moves followed—sustainability initiatives, portfolio adjustments, and 2022's provisioning for Ukraine-related exposures—but the real inflection came as treaty renewals began pricing in rate momentum from 2023 onward.

By 2023, the narrative had shifted decisively. Hannover Rück posted an improved combined ratio around 94%, supported successive earnings upgrades, and increased capital returns through both ordinary and special dividends. The company's ROE expanded, solvency buffers remained solid, and what had once looked cyclical began to resemble something closer to a defensive compounder—the kind that compounds steadily while distributing capital to shareholders.

Investors noticed. The stock absorbed 2020's drawdown, rebounded sharply in 2021 as markets recovered, then endured 2022's macro volatility and large-loss uncertainty. But 2023 brought a sustained breakout. The years that followed—2024 and into 2025—saw rallies built on genuinely improving fundamentals: higher ROE, growing dividends, and earnings momentum that justified a valuation re-rating.

At 267.8 as of April 2026, the share price sits atop that multi-year recovery, reflecting a company that weathered genuine adversity and emerged with stronger pricing power and capital discipline. The pattern here isn't noise—it's a reinsurer that learned to say no to bad business and benefited when the market finally paid for discipline.

Key risks and downside factors

Hannover Rück operates in a tightly consolidated global reinsurance market where a handful of heavyweights—Munich Re, Swiss Re, SCOR, and major US players—essentially dictate pricing and available capacity [3][1]. The company faces meaningful headwinds: concentrated exposure to large natural catastrophes, unpredictable reserve movements, cyclical renewal pricing that routinely squeezes underwriting margins, and the perpetual tug-of-war between investment returns and regulatory capital demands [6][3].

  • Large natural-catastrophe losses could materially reduce Hannover Rück's earnings and capital.
  • Sustained price softening during major renewal seasons tends to compress underwriting margins, putting smaller players at a disadvantage against larger competitors.
  • Reserve estimation errors or adverse development could trigger additional run-off charges and pressure profitability.
  • Shifts in regulatory capital requirements or rating agency decisions could raise the cost of capital or limit market access and expansion opportunities [6].

Competitive landscape

Hannover Rück operates in a concentrated global reinsurance market dominated by heavyweights like Munich Re, Swiss Re, and SCOR, alongside major US competitors who collectively shape pricing and capital allocation [4][2][3][12][17]. The company faces a familiar reinsurance risk profile: exposure to outsized catastrophe losses, reliance on investment returns that swing with market conditions and interest rates, and persistent margin pressure from rivals with deeper balance sheets [4][15][2].

CompanyTicker
Munich ReMUV2.XETRA
Swiss ReSREN.SIX
Reinsurance Group of AmericaRGA.NYSE
AXIS CapitalAXS.NYSE

Private competitors

  • National Indemnity (Berkshire Hathaway subsidiary)
  • Large Lloyd's syndicates (material unlisted competitors)

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Performance Figures of Hannover Rück SE

in EUR

1M High / Low
273.80 / 245.60
52W High / Low
292.60 / 233.00
5Y High / Low
292.60 / 131.35
1M
+4.53%
3M
+0.60%
6M
+4.20%
1Y
-3.27%
3Y
+54.29%
5Y
+84.89%

Relative Performance vs Benchmarks

PeriodHannover Rück SE vs DAX vs S&P 500 (SPY)
1M +4.53% +10.50% +9.52%
3M +0.60% +6.00% +4.97%
6M +4.20% +9.17% +6.47%
1Y -3.27% -6.05% -20.53%
3Y +54.29% +6.06% -10.79%
5Y +84.89% +31.54% +11.07%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current11.51.22.35.2
1Y ago14.71.22.75.8
3Y ago12.70.92.34.1
5Y ago21.10.81.74.7

Key Metrics

Market Capitalization
32.03B EUR
P/E Ratio
12.12
Analyst Target Price

Valuation Metrics

P/S Ratio
1.24
P/B Ratio
2.48

Profitability Metrics

Profit Margin
10.19%
Operating Margin
18.46%
Return on Equity
20.79%
Return on Assets
4.84%

Growth Metrics

Revenue Growth
Earnings Growth

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
202612.50 EUR4.01%
20259.00 EUR3.13%
20247.20 EUR3.09%
20236.00 EUR3.12%
20225.75 EUR3.89%
20214.50 EUR2.92%
20205.50 EUR3.77%
20195.25 EUR3.89%
20185.00 EUR4.22%
20175.00 EUR4.37%
20164.75 EUR4.70%
20154.25 EUR4.76%
20143.00 EUR4.41%
20133.40 EUR5.40%
20122.10 EUR4.47%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

67.2%
Beat estimate
26.2%
Miss estimate
+29.7%
Avg surprise when beat
-15.79%
Avg surprise when miss

Reports analyzed: 61

Upcoming earnings report

May 11, 2026
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus23.51
Range20.76 – 25.23
11 analysts
Est. growth vs prior: 2.32%
Revisions: 7d ↑2 ↓0 · 30d ↑4 ↓3
Next quarter
June 30, 2026
Consensus5.60
Range5.60 – 5.60
1 analysts
Est. growth vs prior: -19.02%
Revisions: 7d ↑1 ↓0 · 30d ↑1 ↓0

Key financial figures

All figures in EUR

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue26.80B2.66B21.98B1.39B26.28B
Operating income (EBIT)26.80B3.21B1.85B1.47B1.73B
Net income2.64B2.33B1.82B780.80M1.23B
Free cash flow5.69B5.68B5.79B5.16B4.60B
Total assets71.33B72.13B65.67B62.96B82.90B
Equity12.93B11.79B10.13B9.06B11.89B
Net debt3.09B3.42B3.82B4.19B3.02B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon